Drug Discovery and Drug delivery system

Gene Therapy and RNA-based Therapeutics

The track on Gene Therapy and RNA-based Therapeutics serves as a beacon for researchers delving into the frontier of genetic medicine. We invite abstract submissions that illuminate groundbreaking advancements in gene therapy and RNA-based therapeutics, elucidating novel strategies to address unmet medical needs and revolutionize disease treatment paradigms.

Attendees can anticipate a dynamic exploration of gene delivery vectors, including viral vectors, nanoparticles, and lipid-based carriers, tailored for efficient gene transfer and expression. Presentations will delve into the intricacies of gene editing technologies such as CRISPR/Cas9, highlighting their potential in correcting genetic aberrations and modulating disease pathways.

Furthermore, discussions will center on the burgeoning field of RNA-based therapeutics, encompassing mRNA vaccines, RNA interference (RNAi) therapies, and antisense oligonucleotides. Attendees will gain insights into the design principles underlying these innovative therapies, their mechanisms of action, and their applications across a spectrum of diseases, including genetic disorders, cancers, and infectious diseases.

Join us in the "Gene Therapy and RNA-based Therapeutics" track at Drug Delivery 2024 conference to engage with leading experts, exchange groundbreaking ideas, and contribute to the advancement of genetic medicine. Together, let us propel the field forward towards transformative therapies that hold the promise of personalized and precision medicine.